UBS O'Connor’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.15M Sell
2025
Q1
$1.36M Buy
2024
Q4
$1.42M Buy
2024
Q3
$1.26M Sell
2024
Q2
$1.13M Buy
2024
Q1
$282K Sell
2023
Q4
$357K Sell
2023
Q3
$778K Sell
2023
Q2
$1.01M Buy
2023
Q1
$537K Buy
2022
Q4
Sell
2022
Q3
$1.78M Buy
2022
Q2
$1.63M Buy